Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Coutant

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
British Journal of Cancer|February 13, 2015
Just how accurate are the major risk stratification systems for early-stage endometrial cancer?S Bendifallah, G Canlorbe, P Collinet, et al.
Breast Cancer Research and Treatment|November 4, 2016
Predictive factors of pathologic complete response of HER2-positive breast cancer after preoperative chemotherapy with trastuzumab: development of a specific predictor and study of its utilities using decision curve analysisClémentine Jankowski, S Guiu, M Cortet, et al.
Breast Cancer Research and Treatment|August 15, 2012
Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancerY Delpech, Y Wu, K R Hess, et al.
Annals of Surgical Oncology|January 7, 2017
Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study GroupL Ouldamer, S Bendifallah, G Body, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 6, 2017
Prognostic value of local relapse for patients with endometrial cancerY Dabi, J Uzan, S Bendifallah, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 5, 2013
Evaluation and impact of residual disease in locally advanced cervical cancer after concurrent chemoradiation therapy: results of a multicenter studyD Hequet, E Marchand, V Place, et al.
Annals of Surgical Oncology|July 11, 2020
Prognostic Value and Risk Factors of Peritoneal Carcinomatosis Recurrence for Patients with Endometrial Cancer: A Multicenter Study from the FRANCOGYN GroupA Gaudet Chardonnet, H Azaïs, M Ballester, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 11, 2017
Patterns of care and the survival of elderly patients with high-risk endometrial cancer: A case-control study from the FRANCOGYN groupA Rousselin, S Bendifallah, K Nyangoh Timoh, et al.
British Journal of Cancer|October 31, 2013
Impact of sentinel node biopsy on long-term quality of life in breast cancer patientsE De Gournay, A Guyomard, C Coutant, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 18, 2020
Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by interval debulking surgery: A multicenter cohort analysis from the FRANCOGYN study groupL Vincent, C Jankowski, L Ouldamer, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
British Journal of Cancer|February 13, 2015
Just how accurate are the major risk stratification systems for early-stage endometrial cancer?S Bendifallah, G Canlorbe, P Collinet, et al.
Breast Cancer Research and Treatment|November 4, 2016
Predictive factors of pathologic complete response of HER2-positive breast cancer after preoperative chemotherapy with trastuzumab: development of a specific predictor and study of its utilities using decision curve analysisClémentine Jankowski, S Guiu, M Cortet, et al.
Breast Cancer Research and Treatment|August 15, 2012
Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancerY Delpech, Y Wu, K R Hess, et al.
Annals of Surgical Oncology|January 7, 2017
Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study GroupL Ouldamer, S Bendifallah, G Body, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 6, 2017
Prognostic value of local relapse for patients with endometrial cancerY Dabi, J Uzan, S Bendifallah, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 5, 2013
Evaluation and impact of residual disease in locally advanced cervical cancer after concurrent chemoradiation therapy: results of a multicenter studyD Hequet, E Marchand, V Place, et al.
Annals of Surgical Oncology|July 11, 2020
Prognostic Value and Risk Factors of Peritoneal Carcinomatosis Recurrence for Patients with Endometrial Cancer: A Multicenter Study from the FRANCOGYN GroupA Gaudet Chardonnet, H Azaïs, M Ballester, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 11, 2017
Patterns of care and the survival of elderly patients with high-risk endometrial cancer: A case-control study from the FRANCOGYN groupA Rousselin, S Bendifallah, K Nyangoh Timoh, et al.
British Journal of Cancer|October 31, 2013
Impact of sentinel node biopsy on long-term quality of life in breast cancer patientsE De Gournay, A Guyomard, C Coutant, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 18, 2020
Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by interval debulking surgery: A multicenter cohort analysis from the FRANCOGYN study groupL Vincent, C Jankowski, L Ouldamer, et al.
Pageof 8